SCHEMBL29567052

SCHEMBL29567052

O=[N+]([O-])c1cccc(S(=O)(=O)Nc2nc(Cl)cc(Cl)n2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.60
▸ LMNA P02545 1/20 0.60
▸ KMT2A Q03164 3/20 0.59
▸ MEN1 O00255 1/20 0.59
▸ CA1 P00915 1/20 0.57
▸ CA2 P00918 1/20 0.57
▸ MMP1 P03956 1/20 0.57
▸ MMP2 P08253 1/20 0.57
▸ MMP9 P14780 1/20 0.57
▸ MMP8 P22894 1/20 0.57
▸ MMP13 P45452 1/20 0.57
▸ FBP1 P09467 1/20 0.57
▸ KDM1A O60341 2/20 0.56
▸ DDX3X O00571 1/20 0.55
▸ CYP19A1 P11511 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ NFKBIA P25963 1/20 0.54
▸ RELA Q04206 1/20 0.54
▸ EDNRA P25101 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24298639 1.00 ALDH1A1 (0.60) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL29566554 0.87 PGR (0.64) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL24309294 0.87 PGR (0.64) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL29457779 0.86 LMNA (0.55) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL24330660 0.86 LMNA (0.55) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL26868831 0.84 LMNA (0.57) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL24309251 0.84 LMNA (0.52) ALDH1A1LMNAKMT2AMEN1FBP1
SCHEMBL29566909 0.84 LMNA (0.52) ALDH1A1LMNAKMT2AMEN1FBP1
SCHEMBL29566547 0.83 LMNA (0.51) ALDH1A1LMNAKMT2AMEN1CA1
SCHEMBL24309308 0.83 LMNA (0.51) ALDH1A1LMNAKMT2AMEN1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback